Hydrophilic high quantum yield acridinium esters with improved stability and fast light emission

US12275708B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12275708-B2
Application numberUS-202418442393-A
CountryUS
Kind codeB2
Filing dateFeb 15, 2024
Priority dateJul 8, 2013
Publication dateApr 15, 2025
Grant dateApr 15, 2025

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Hydrophilic, high quantum yield, chemiluminescent acridinium compounds with increased light output, improved stability, fast light emission and decreased non specific binding are disclosed. The chemiluminescent acridinium esters possess hydrophilic, branched, electron-donating functional groups at the C2 and/or C7 positions of the acridinium nucleus.

First claim

Opening claim text (preview).

The invention claimed is: 1. An acridinium compound having the structure: wherein, R 1 is a methyl or sulfopropyl group; R 2a is alkylene or arylene, R 3a is alkyl or aryl, G is, at both occurrences, a branched group selected from: and R 12 is selected from the group consisting of (1) —OH; (2) —O—N-succinimidyl; (3) —NH—(CH 2 ) 5 —C(O)—O—N-succinimidyl; (4) —NH—(CH 2 ) 5 —COOH; (5) —NH—(C 2 H 4 O) p —C 2 H 4 NH—C(O)—(CH 2 ) 3 —C(O)—O—N—R″ wherein p=1 to 5; and where R″ is hydrogen or —N-succinimidyl; and (6) —NH—(C 2 H 4 O) q —C 2 H 4 NH 2 , wherein q=1 to 5. 2. The acridinium compound according to claim 1 , wherein G is a group: at both occurrences. 3. The acridinium compound according to claim 1 , wherein G is a group: at both occurrences. 4. The acridinium compound according to claim 1 , wherein G is a group: at both occurrences. 5. The acridinium compound according to claim 1 , wherein G is a group: at both occurrences. 6. The acridinium compound according to claim 1 , wherein said acridinium compound is characterized in that ≥89% of the chemiluminescence of said acridinium compound is emitted within one second of said adding chemiluminescence triggering reagents. 7. The acridinium compound according to claim 1 , wherein said acridinium compound is characterized in that said acridinium compound retains more than 60% of its chemiluminescent activity after 33 days at 37° C. 8. A method for the detection or quantification of an analyte in a sample suspected of containing the analyte comprising the steps of: (a) providing a conjugate comprising (i) an antibody specific for the analyte; and (ii) an acridinium compound having the structure: wherein, R 1 is a methyl or sulfopropyl group; R 2a is alkylene or arylene, R 3a is alkyl or aryl, G is, at both occurrences, a branched group selected from: and R 12 is conjugated to the antibody specific for the analyte; (b) providing a solid support having immobilized thereon a second antibody specific for the analyte; (c) mixing the conjugate, the solid phase and the sample suspected of containing the analyte to form a binding complex; (d) separating the binding complex captured on the solid support; (e) triggering chemiluminescence of the binding complex from step (d) by adding chemiluminescence triggering reagents; (f) detecting the presence or calculating the concentration of the analyte by comparing the amount of light emitted from the reaction mixture with a standard dose response curve which relates the amount of light emitted to a known concentration of the analyte. 9. The method according to claim 8 , wherein R 12 is formed from the antibody reacting with one of: (1) —OH; (2) —O—N-succinimidyl; (3) —NH—(CH 2 ) 5 —C(O)—O—N-succinimidyl; (4) —NH—(CH 2 ) 5 —COOH; (5) —NH—(C 2 H 4 O) p —C 2 H 4 NH—C(O)—(CH 2 ) 3 —C(O)—O—N—R″ wherein p=1 to 5; and where R″ is hydrogen or —N-succinimidyl; and (6) —NH—(C 2 H 4 O) q —C 2 H 4 NH 2 , wherein q=1 to 5.

Assignees

Inventors

Classifications

  • having chemically-interreactive components, e.g. reactive chemiluminescent compositions · CPC title

  • with an insoluble carrier for immobilising immunochemicals · CPC title

  • with fluorescent label · CPC title

  • using chemiluminescence · CPC title

  • Chemiluminescence; Bioluminescence · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12275708B2 cover?
Hydrophilic, high quantum yield, chemiluminescent acridinium compounds with increased light output, improved stability, fast light emission and decreased non specific binding are disclosed. The chemiluminescent acridinium esters possess hydrophilic, branched, electron-donating functional groups at the C2 and/or C7 positions of the acridinium nucleus.
Who is the assignee on this patent?
Siemens Healthcare Diagnostics Inc
What technology area does this patent fall under?
Primary CPC classification C07D219/06. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Apr 15 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).